Bronnen:
- Lee CK, Man J, Lord S et al. Clinical and molecular characteristics associated with survival among patients treated with checkpoint inhibitors for advanced non–small cell lung carcinoma. A systematic review and meta-analysis. JAMA Oncology. 2018;4(2):210-216.